LIGAND PHARMACEUTICALS INCORPORATED Common Stock ($0.001 par value per share) AT-THE-MARKET EQUITY OFFERING SALES AGREEMENTLigand Pharmaceuticals Inc • September 30th, 2022 • Pharmaceutical preparations • New York
Company FiledSeptember 30th, 2022 Industry Jurisdiction